As peroral bioavailability of drugs will be primarily affected by intestinal P-gp and patients with PaC and DM are usually prescribed multiple medications, it is of great importance to evaluate the intestinal P-gp expression in these patients. This evidence concerns the gene PGP and diabetes mellitus.